CIK: 0001388325 · Show all filings
Period: Q2 2014 (← Previous) (Next →)
Filing Date: Nov 14, 2014
Total Value ($000): $1,023,917
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| VTI | VANGUARD INDEX FDS | 2,979,100 | $303,183 | 29.6% | $57.39 | — | — | 922908769 |
| — | OPHTHOTECH CORP | 6,910,489 | $292,383 | 28.6% | $32.35 | — | — | 683745103 |
| VGK | VANGUARD INTL EQUITY INDEX F | 2,101,000 | $125,955 | 12.3% | $45.01 | — | — | 922042874 |
| INGN | INOGEN INC | 5,419,449 | $122,263 | 11.9% | $17.78 | -6.8% | — | 45780L104 |
| — | ALDER BIOPHARMACEUTICALS INC | 3,201,183 | $64,248 | 6.3% | $20.07 | — | — | 014339105 |
| AKBA | AKEBIA THERAPEUTICS INC | 1,516,387 | $42,140 | 4.1% | $24.08 | 0.0% | — | 00972D105 |
| — | FLEXION THERAPEUTICS | 1,783,131 | $24,037 | 2.3% | $16.45 | — | — | 33938J106 |
| — | WRIGHT MED GROUP INC | 585,759 | $18,393 | 1.8% | $23.81 | — | — | 98235T107 |
| — | TETRAPHASE PHARMACEUTICALS INC | 900,000 | $12,141 | 1.2% | $13.52 | — | — | 88164N105 |
| — | TETRAPHASE PHARMACEUTICALS INC | 900,000 | $12,141 | 1.2% | $13.52 | — | — | 88165N105 |
| — | WRIGHT MED GROUP INC | 4,720,065 | $7,033 | 0.7% | $2.50 | — | — | 98235T115 |